טוען...
Trends in anti-D immune globulin for childhood immune thrombocytopenia: Usage, response rates, and adverse effects
In 2010, the Food and Drug Administration (FDA) added a black box warning to anti-D immune globulin (Rho(D) immune globulin, anti-D) for immune thrombocytopenia (ITP) to warn of the complications related to severe hemolysis. The objective of this retrospective medical record review was to examine re...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3767405/ https://ncbi.nlm.nih.gov/pubmed/22190130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.22261 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|